Bio-Cancer Treatment International Overview
- Year Founded
-
2000
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
7
Bio-Cancer Treatment International General Information
Description
Developer of human malignancies and auto-immune disorders treatment intend to safe and effective treatments of multiple cancer indications and auto-immune disorders. The company's patented drugs are arginine depleting agents that retard tumor growth, enabling patients to get treated and cured in an effective and easy way.
Contact Information
Website
www.bio-cancer.comCorporate Office
- Room 302, 3/F Building 20E, 20 Science Park East Avenue
- Hong Kong Science Park, New Territories, Shatin District
- Hong Kong
- Hong Kong
Corporate Office
- Room 302, 3/F Building 20E, 20 Science Park East Avenue
- Hong Kong Science Park, New Territories, Shatin District
- Hong Kong
- Hong Kong
Bio-Cancer Treatment International Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 01-Sep-2016 | Completed | Clinical Trials - Phase 2 | |||
| 6. Grant | 01-Jan-2014 | Completed | Clinical Trials - Phase 2 | |||
| 5. Grant | 01-Jan-2010 | Completed | Clinical Trials - Phase 1 | |||
| 4. Later Stage VC | 01-Jan-2006 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 01-Jan-2004 | Completed | Startup | |||
| 2. Grant | 01-Jan-2002 | Completed | Startup | |||
| 1. Grant | 01-Jan-2001 | Completed | Startup |
Bio-Cancer Treatment International Patents
Bio-Cancer Treatment International Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021256801-A1 | Methods of treating viral infections using arginase | Inactive | 17-Apr-2020 | ||
| CA-3180529-A1 | Methods of treating viral infections using arginase | Pending | 17-Apr-2020 | ||
| EP-4135754-A1 | Methods of treating viral infections using arginase | Inactive | 17-Apr-2020 | ||
| EP-4135754-A4 | Methods of treating viral infections using arginase | Inactive | 17-Apr-2020 | ||
| US-20230149521-A1 | Methods of treating viral infections using arginase | Inactive | 17-Apr-2020 | A61K38/50 |
Bio-Cancer Treatment International Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HKSTP Ventures | Corporate Venture Capital | Minority | ||
| Hong Kong Science & Technology Parks | Accelerator/Incubator | Minority | ||
| Pivotal Life Sciences | Asset Manager | Minority | ||
| Government of China | Government | |||
| Shanghai Municipal Government | Government |
Bio-Cancer Treatment International FAQs
-
When was Bio-Cancer Treatment International founded?
Bio-Cancer Treatment International was founded in 2000.
-
Where is Bio-Cancer Treatment International headquartered?
Bio-Cancer Treatment International is headquartered in Hong Kong, Hong Kong.
-
What industry is Bio-Cancer Treatment International in?
Bio-Cancer Treatment International’s primary industry is Drug Discovery.
-
Is Bio-Cancer Treatment International a private or public company?
Bio-Cancer Treatment International is a Private company.
-
What is Bio-Cancer Treatment International’s current revenue?
The current revenue for Bio-Cancer Treatment International is .
-
Who are Bio-Cancer Treatment International’s investors?
HKSTP Ventures, Hong Kong Science & Technology Parks, Pivotal Life Sciences, Government of China, and Shanghai Municipal Government are 5 of 7 investors who have invested in Bio-Cancer Treatment International.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process